Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gamma Interferon for Chronic Hepatitis C
NCT00028275Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Dec 2001
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon gamma-1b in hepatitis C (HCV), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Dec 2001; status: completed.
02
Drugs
interferon gamma-1b
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00028275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028275.